Lipopolysaccharide administration enhances hypoxic-ischemic brain damage in newborn rats

Li Yang1, Hiroshi Sameshima, Tomoaki Ikeda

  • 1Department of Obstetrics and Gynecology, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan.

Insights

Inflammation from lipopolysaccharide (LPS) worsens brain damage caused by hypoxic-ischemic (HI) insult in newborn rats. This effect increases with higher LPS doses, indicating LPS potentiates HI-induced brain injury.

Area of Science:

  • Neuroscience
  • Perinatal Medicine
  • Toxicology

Background:

  • Hypoxic-ischemic (HI) insult is a major cause of brain damage in newborns.
  • Inflammation is suspected to exacerbate HI-induced brain injury.
  • Lipopolysaccharide (LPS) is a potent inflammatory agent.

Purpose of the Study:

  • To investigate the combined effect of inflammation and HI insult on perinatal brain damage.
  • To examine the dose-response relationship of LPS administration on HI insult in neonatal rats.

Main Methods:

  • Neonatal Wistar rats received pre-injections of LPS (0.1, 0.5, or 1 mg/kg) or saline.
  • Rats underwent unilateral carotid artery ligation followed by hypoxia.
  • Neuronal damage was assessed histologically seven days post-insult.

Main Results:

  • Mortality significantly increased in the highest LPS dose group (1 mg/kg LPS/HI).
  • No neuronal damage occurred in rats receiving LPS alone.
  • LPS significantly increased neuronal loss in the cerebral cortex and hippocampus in a dose-dependent manner when combined with HI.

Conclusions:

  • Lipopolysaccharide (LPS) potentiates hypoxic-ischemic (HI) insult.
  • The potentiation of HI insult by LPS is dose-dependent.
  • Inflammation exacerbates HI-induced brain damage in neonatal rats.
Abstract

Related Concept Videos